01:53 AM EDT, 07/23/2026 (MT Newswires) -- Galderma Group (GALD.SW) said Thursday its net income and net sales in the first half surged year over year. Net income for the six months ended June 30 was $444 million, compared with $194 million earlier. EPS moved to $1.89 from $0.82. The dermatology company's net sales were $3.13 billion, compared with $2.45 billion a year ago. Looking ahead, the group increased its guidance for net sales growth to between 19% and 21%, at constant currency, compared with earlier projections of between 17% and 20%.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.